Parallel Advisors, LLC
- SEC CIK
- 0001690010
- Latest filing
- Aug 5, 2026
SNDX holding history
Syndax Pharmaceuticals Inc in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SNDX overviewAll 13F holders of SNDXFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −96−100.0% | Sold out | Holders |
| Q2 2025 | 96 | $899 | <0.1% | −236−71.1% | Reduced | Holders |
| Q1 2025 | 332 | $4.08K | <0.1% | −29−8.0% | Reduced | Holders |
| Q4 2024 | 361 | $4.77K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 361 | $6.95K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 361 | $7.41K | <0.1% | −124−25.6% | Reduced | Holders |
| Q1 2024 | 485 | $11.5K | <0.1% | +124+34.3% | Added | Holders |
| Q4 2023 | 361 | $7.80K | <0.1% | −125−25.7% | Reduced | Holders |
| Q3 2023 | 486 | $7.06K | <0.1% | +486 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −20−100.0% | Sold out | Holders |
| Q3 2022 | 20 | $0 | 0.0% | +11+122.2% | Added | Holders |
| Q2 2022 | 9 | $0 | 0.0% | +9 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −13−100.0% | Sold out | Holders |
| Q4 2021 | 13 | $0 | 0.0% | +13 | New | Holders |